Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah. �Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium). �He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy. �Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant. �For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia. �This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion. �His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure. �Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process. �To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is highly rated in 15 conditions, according to our data. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Hassan Yaish is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Yaish is highly rated in 12 conditions, according to our data. His top areas of expertise are Pyruvate Kinase Deficiency, Hereditary Spherocytosis, Hemolysis, Anemia, and Splenectomy.

Joshua Schiffman is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Schiffman is highly rated in 5 conditions, according to our data. His top areas of expertise are Ewing Sarcoma, Adult Soft Tissue Sarcoma, Osteosarcoma, and Rhabdomyosarcoma.

Carol Bruggers is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Bruggers is highly rated in 4 conditions, according to our data. Her top areas of expertise are Ganglioglioma, Rhabdoid Tumor, Glioma, and Teratoma of the Mediastinum.

Michael Boyer is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Boyer is highly rated in 4 conditions, according to our data. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Hepatic Venoocclusive Disease with Immunodeficiency, Childhood Acute Myeloid Leukemia, and Bone Marrow Transplant.

Luke Maese is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Maese is highly rated in 3 conditions, according to our data. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration.

Richard Lemons, MD, PhD, is a professor in the Department of Pediatrics at the University of Utah School of Medicine, medical director and chief of pediatric hematology/oncology at Primary Children's Medical Center and the University of Utah, and a Huntsman Cancer Institute investigator. He is involved in various clinical trials for pediatric malignancies and pediatric hematologic disorders.Lemons earned a medical degree from George Washington University School of Medicine, Washington, DC; and performed an internship and residency at Johns Hopkins Hospital, Baltimore. Lemons was a staff member at St. Jude Children's Research Hospital prior to joining the University of Utah Department of Pediatrics. He is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Lemons is highly rated in 3 conditions, according to our data. His top areas of expertise are Hemophilia B, Infantile Neutropenia, Blood Clots, and Hemophilia A.

Dr. McNeer is a Professor of Clinical Pediatrics at the University of Utah School of Medicine in the Division of Pediatric Hematology/Oncology and is the Medical Director for Pediatric Hematology/Oncology at Primary Children's Hospital. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children's Hospital.After receiving her medical degree from New York University School of Medicine, Dr. McNeer completed her residency at Children's Memorial Hospital (now Lurie Children's Hospital), which is affiliated with Northwestern University Feinberg School of Medicine. She then completed her fellowship in Pediatric Hematology/Oncology/Stem Cell Transplant at Children's Memorial Hospital, and during her fellowship earned a master's degree in clinical investigation at Northwestern University Feinberg School of Medicine.Dr. McNeer is board-certified in Pediatrics and Pediatric Hematology and Oncology. She has authored over 25 peer-reviewed journal articles and 4 book chapters. Dr. McNeer has been an invited speaker at many national and international conferences and symposiums. She is a member of the American Society of Clinical Oncology, American Society of Hematology, as well as the American Society of Pediatric Hematology/Oncology and the Children's Oncology Group.Dr. McNeer's clinical expertise is in the treatment of children, adolescents, and young adults with hematologic malignancies such as leukemia and lymphoma, in particular those with high-risk and relapsed/refractory acute lymphoblastic leukemia. She has a leadership role within the Children's Oncology Group Acute Lymphoblastic Leukemia committee, and partners with colleagues in adult oncology to collaborate in developing treatment protocols and clinical trials for young adults with leukemia. Her research focus is on the design and implementation of clinical trials for patients with hematologic malignancies.Dr. McNeer is invested in improving overall treatment outcomes for children, adolescents, and young adults, while tailoring therapy and supportive care to individual patients in order to minimize toxicity and optimize quality of life. Dr. Mcneer is highly rated in 2 conditions, according to our data. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Febrile Neutropenia, Infantile Neutropenia, and Bone Marrow Aspiration.

Zeinab Afify is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Afify is highly rated in 2 conditions, according to our data. Her top areas of expertise are X-Linked Lymphoproliferative Disease, Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Phillip Barnette is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Barnette is highly rated in 18 conditions, according to our data. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Leukemia, Hepatoblastoma, and Bone Marrow Aspiration.

Dr. Dietz received his degrees in medicine and medical education from the University of New England. He completed his Pediatric Residency and Hematology and Oncology Fellowship at Oregon Health & Science University where he also served as chief resident.In 2020 Dr. Dietz joined the faculty of the University of Utah, where he is currently an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Clinically, Dr. Dietz focuses on the care of pediatric and young adult patients with bone and soft tissue sarcoma, as well as children with retinoblastoma. He is the Associate Director of the Primary Children's Hospital Solid Tumor Program and leads the Comprehensive Retinoblastoma Program. Dr. Dietz is committed to delivering cutting edge clinical care, as well as providing patients with access to experimental therapeutics and discovery programs.�Dr. Dietz's research efforts include team science approaches to better understand the biology driving cancer progression and treatment resistance with a focus on translating this work into new therapies. He is a member of the Huntsman Cancer Institute's Experimental Therapeutics Program and actively involved in the development of early phase clinical trials through multiple cooperative consortia including the Children's Oncology Group, The Sunshine Project, the Pediatric Oncology Experimental Therapeutics Investigator's Consortium, and the Pediatric Early Phase Clinical Trial Network. Dr. Dietz is highly rated in 8 conditions, according to our data. His top areas of expertise are Ewing Sarcoma, Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.

Mark Fluchel is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Fluchel is highly rated in 5 conditions, according to our data. His top areas of expertise are Non-Langerhans-Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis, Histiocytosis, and Reticulohistiocytoma.

Anupam Verma is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Verma is highly rated in 3 conditions, according to our data. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Infantile Neutropenia, and Febrile Neutropenia.

Nicholas Whipple is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Whipple is highly rated in 2 conditions, according to our data. His top areas of expertise are Glioma, Anemia, Sickle Cell Disease, and Hemolytic Anemia.

Ahmad Rayes is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Rayes is highly rated in 2 conditions, according to our data. His top areas of expertise are Severe Combined Immunodeficiency (SCID), Chronic Graft Versus Host Disease (cGvHD), Chronic Granulomatous Disease, Infantile Neutropenia, and Bone Marrow Transplant.

Dr. Meznarich received her medical degree from the University of Washington School of Medicine in Seattle, Washington. She then completed her residency in Pediatrics and fellowship in Pediatric Hematology and Oncology at the University of Utah/Primary Children's Hospital in Salt Lake City, Utah.She joined the faculty of the University of Utah in 2016, where she is currently an Associate Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. �Her clinical and research interests are in non-malignant hematology, bleeding disorders, thrombosis and clotting disorders, and hemoglobinopathies including thalassemia and sickle cell disease. Dr. Meznarich is highly rated in 1 condition, according to our data. Her top areas of expertise are Anemia, Hemolytic Disease of the Newborn, Infantile Pyloric Stenosis, and DiGeorge Syndrome.

Dr. Pyper is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Hematology team at the University of Utah and Primary Children's Hospital. He received his medical degree from Northwestern University Feinberg School of Medicine.Dr. Pyper completed his residency at the University of Vermont College of Medicine, University of Vermont Children's Hospital (Pediatrics). He completed his fellowship in Pediatric Hematology, Oncology and Bone Marrow Transplantation at the University of Minnesota Medical School, University of Minnesota Masonic Children's Hospital.Dr. Pyper is board-certified in Pediatrics and Pediatric Hematology and Oncology. He is a member of many professional societies, including The American Society of Pediatric Hematology/Oncology, The American Society for Hematology and the American Society for Transplantation and Cellular Therapy. He has many years teaching experience and has previously been awarded teacher of the year by the associated pediatric residency program. He also takes great interest in patient and family education to make sure that patients and families understand their medical issues in an age-appropriate way so that they are able to participate in decision-making and advocate well for themselves and their loved ones.Dr. Pyper's clinical interests include the treatment of pediatric disorders including non-malignant hematology, disorders of hemostasis and thrombosis, sickle cell disease, red cell membrane defects and hemoglobinopathies as well as bone marrow failure syndromes.His primary research interests include congenital and acquired risk factors for abnormal bleeding and clotting in pediatric patients as well as improving access to needed health care resources for high-risk pediatric patients affected by hematologic diseases. Dr. Pyper is highly rated in 1 condition, according to our data. His top areas of expertise are Hereditary Spherocytosis, Hemolytic Anemia, Acute Lymphoblastic Leukemia (ALL), and Congenital Hemolytic Anemia.

Dr. Mangum received his medical degree from the Albert Einstein College of Medicine (affiliated with Yeshiva University). He then completed his Pediatric residency at Primary Children�s Hospital (affiliated with the University of Utah), which was followed by a pediatric Hematology Oncology Fellowship at St Jude Children's Research Hospital (affiliated with the University of Tennessee). Afterwards, he completed an additional two year Physician Scientist Training Program fellowship at St. Jude Children's Research Hospital while still also continuing to care for patients. Following this, Dr. Mangum joined the faculty of Nemours Children's Hospital in Delaware where he practiced for three years in pediatric hematology oncology. Dr. Mangum then joined the University of Utah in the Division of Pediatric Hematology Oncology at Primary Children's Hospital. Dr. Mangum's research interests have focused primarily on Acute Lymphoblastic Leukemia, with his clinical interests focused on patients with Leukemias, Lymphomas, and histiocytic disorders of all kinds. However, he is comfortable with caring for any patient across the entire pediatric hematology oncology spectrum. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Rosai-Dorfman Disease, and Immune Thrombocytopenic Purpura (ITP).

Jennifer Wright is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Her top areas of expertise are Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Adult Soft Tissue Sarcoma, and Rhabdomyosarcoma.

Elaine Fan is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Her top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Shwachman-Diamond Syndrome, and Hereditary Spherocytosis.

Mary Underdown is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Her top areas of expertise are Desmoplastic Small Round Cell Tumor, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Ewing Sarcoma, and Anemia.

Douglas Fair is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. His top areas of expertise are Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, and Immune Thrombocytopenic Purpura (ITP).

J Dolan is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Dolan has been practicing medicine for over 6 years. His top areas of expertise are Hereditary Neuroblastoma, Neuroblastoma, Acute Lymphoblastic Leukemia (ALL), and Immune Thrombocytopenic Purpura (ITP). Dr. Dolan is currently accepting new patients.

Dr. Chan received her medical degree from the University of Minnesota Medical School, completed her Pediatric Residency at the University of Wisconsin, and her Pediatric Hematology/Oncology Fellowship at the University of Utah. Following fellowship she completed a Pediatric Neuro-Oncology Fellowship at the University of Colorado/Children's Hospital Colorado.Dr. Chan is currently an Assistant Professor of Pediatrics at the University of Utah in the Division of Pediatric Hematology/Oncology. She is a member of the neuro-oncology team at Primary Children's Medical Center.Dr. Chan's clinical interests include the care of children and young adults with brain and spine tumors. Dr. Chan's research interests are focused on the development of early phase clinical trials for children with central nervous system tumors and the long-term care of patients who have survived these cancers. Her top areas of expertise are Glioma, Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP).

Dr. Goteti received his medical degree from Ross University School of Medicine, completed his Pediatric residency at Golisano Children's Hospital at SUNY Upstate Medical University, where he also served as a chief resident, and his Hematology-Oncology Fellowship at Oregon Health and Science University.Dr. Goteti is an Assistant Professor in the division of Pediatric Hematology/Oncology/BMT at the University of Utah School of Medicine. His clinical interests are hemoglobinopathies, immune-hematology, bone marrow failure syndromes, and platelet disorders. He serves as the institutional lead in sickle cell disease and thalassemia. He is the site PI for the Pacific Sickle Cell Regional Collaborative (PSCRC) and the Globin Regional Data and Discovery (GRANDaD) studies. He leads multiple quality improvement initiatives and recently received the American Society of Hematology Quality Improvement Training Initiative award. His top areas of expertise are Shwachman-Diamond Syndrome, Infantile Neutropenia, and Immune Thrombocytopenic Purpura (ITP).